A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy (clinicaltrials.gov) - Feb 12, 2025 - P2 | N=84 | Not yet recruiting | Sponsor: Shandong Suncadia Medicine Co., Ltd.
New P2 trial • Cardiomyopathy • Cardiovascular • Hypertrophic Cardiomyopathy • Non-obstructive Hypertrophic Cardiomyopathy
|